These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18676439)

  • 41. A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
    Dwyer M; Bergsland N; Hussein S; Durfee J; Wack D; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):86-95. PubMed ID: 19386319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fractal dimension analysis of grey matter in multiple sclerosis.
    Esteban FJ; Sepulcre J; de Miras JR; Navas J; de Mendizábal NV; Goñi J; Quesada JM; Bejarano B; Villoslada P
    J Neurol Sci; 2009 Jul; 282(1-2):67-71. PubMed ID: 19167728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis.
    Favaretto A; Lazzarotto A; Riccardi A; Pravato S; Margoni M; Causin F; Anglani MG; Seppi D; Poggiali D; Gallo P
    PLoS One; 2017; 12(10):e0185626. PubMed ID: 29045421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
    Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting.
    Eissa A; Lebel RM; Korzan JR; Zavodni AE; Warren KG; Catz I; Emery DJ; Wilman AH
    J Magn Reson Imaging; 2009 Oct; 30(4):737-42. PubMed ID: 19787716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple sclerosis and the accumulation of iron in the Basal Ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry.
    Burgetova A; Seidl Z; Krasensky J; Horakova D; Vaneckova M
    Eur Neurol; 2010; 63(3):136-43. PubMed ID: 20130410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
    Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
    Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal Ganglia.
    Kolbe SC; Garcia LM; Yu N; Boonstra FM; Clough M; Sinclair B; White O; van der Walt A; Butzkueven H; Fielding J; Law M
    AJNR Am J Neuroradiol; 2022 Feb; 43(2):238-244. PubMed ID: 35121585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer's disease patients and normal elderly from the Sunnybrook Dementia Study.
    Ramirez J; Berezuk C; McNeely AA; Scott CJ; Gao F; Black SE
    J Alzheimers Dis; 2015; 43(2):415-24. PubMed ID: 25096616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
    Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neuroradiological study of cerebral microlesions (2): changes in elderly].
    Qu H; Nishimaru K; Utsunomiya H; Une H
    No To Shinkei; 2003 Aug; 55(8):675-82. PubMed ID: 13677301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of Virchow-Robin spaces in patients newly diagnosed with multiple sclerosis: a case-control study in an Arab population.
    Al-Saeed O; Athyal R; Ismail M; Sheikh M
    Med Princ Pract; 2012; 21(5):447-51. PubMed ID: 22538555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
    Cercignani M; Basile B; Spanò B; Comanducci G; Fasano F; Caltagirone C; Nocentini U; Bozzali M
    NMR Biomed; 2009 Jul; 22(6):646-53. PubMed ID: 19322806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.
    van den Elskamp IJ; Lembcke J; Dattola V; Beckmann K; Pohl C; Hong W; Sandbrink R; Wagner K; Knol DL; Uitdehaag B; Barkhof F
    Mult Scler; 2008 Jul; 14(6):764-9. PubMed ID: 18611989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testosterone treatment in multiple sclerosis: a pilot study.
    Sicotte NL; Giesser BS; Tandon V; Klutch R; Steiner B; Drain AE; Shattuck DW; Hull L; Wang HJ; Elashoff RM; Swerdloff RS; Voskuhl RR
    Arch Neurol; 2007 May; 64(5):683-8. PubMed ID: 17502467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
    Caramanos Z; DiMaio S; Narayanan S; Lapierre Y; Arnold DL
    J Neurol Sci; 2009 Jul; 282(1-2):72-9. PubMed ID: 19232641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.